Background: Dermatologic complications are common in patients with end-stage
Cutaneous complications are common in patients with ESRD. 3 Recent advances in the treatment of chronic kidney disease lead to increasing survival of patients with ESRD. 4 Therefore, the incidence of cutaneous disease in these patients will likely increase as well.
About 50%-100% of patients with ESRD have at least one associated dermatologic problem. 5, 6 In a recent study by Thomas et al, almost all patients with CKD (97%) had one or more skin manifestations, 7 and Tajbakhsh et al showed skin abnormalities in 95% of the patients. According to reports, the incidence of cutaneous manifestations in patients on HD varies in different region of Iran. 8 These differences may be caused by factors such as race, nutritional condition, geographic location, socioeconomic status of the patients, and accuracy of skin examination. 2, 5 This study aimed to systematically review all of the studies on prevalence of cutaneous and mucosal manifestations in the patients with ESRD among Iranian population. We followed a comprehensive approach to conducting an up-to-date systematic review and metaanalytic comparison of all available studies.
2 | ME TH ODS
| Search strategy
The relevant empirical literature was identified by searching several 
Inclusion and exclusion criteria
We included all available hospital-based studies including cross-sectional and case-control studies. We excluded studies with duplicate citation. When there were multiple publications from the same population, only the largest study was included.
Data extraction
Data were collected according to a standard protocol independently by two authors. Disagreement was resolved by a third expert reviewer. The extracted information from the literature included the name of the first author, the year of publication, the study region, total sample size, age and sex groups, duration of hemodialysis, type of dermatological manifestations and reported frequency of dermatological manifestations, and its 95% confidence interval.
| Statistical analysis
Meta-analysis was performed only for dermatological manifestations that reported in more than five studies. The reported prevalence is presented as number and percentage. Heterogeneity of reported prevalence's between studies was assessed by the Chi-squared-based Q test and I-squared statistics. The result of Q test was regarded to be statistically significant at P < .1. Due to sever heterogeneity among studies regarding the reported prevalence of dermatological manifestations in Iran, overall prevalence was estimated using random-effect meta-analysis model (using the Der-Simonian and Laird method). Forest plot also was used to present result of meta-analysis schematically.
The analyses were conducted with STATA software, version 11.0.
| RESULTS
The flow diagram of the study selection process is shown in Figure 1. The search yielded 1229 publications that were related to our topic. According to titles, 1216 publications were excluded as clearly ineligible, leaving 13 for further review. In next step, we obtained copies of the full published version of each study, which were then carefully assessed against inclusion/exclusion criteria. After reading abstracts, five publications were excluded at this stage, leaving nine publications that were provisionally eligible. Finally, after exclusion of one duplicated publications, eight studies were fully eligible for inclusion in this meta-analysis.
All of the included studies had been reported dermatological complications prevalence among hemodialysis patients. In one study, dermatological complications were reported separately in four categories as the skin, mucus, nails, and hair. In the rest of the studies, this classification has not been made and has addressed a number of major complications in these patients. The extracted data from these studies are shown separately in Tables 1 and 2 .
In all of the studies, skin discoloration, pruritus, and xerosis have the highest prevalence. The prevalence of skin discoloration varied between 30% and 77.7%. The lowest and highest prevalence of pruritus and xerosis is 38.6% to 70% and 7.3% to 78.3%, respectively.
The results of meta-analysis for skin discoloration, pruritus, ecchymosis, xerosis, and half-and-half nail are presented in Table 3 .
Considering the severe heterogeneity among reported values, to overall estimation of prevalence, for possible variables, we used random-effect model.
According to random-effect meta-analysis model, the pooled prevalence of skin discoloration, pruritus, ecchymosis, xerosis, and | 207 discoloration, pruritus, xerosis, and half-and-half nail, has been reported in all studies. We conducted a meta-analysis of data for the complications which is those prevalence reported in more than five studies.
The prevalence of skin discoloration, pruritus, ecchymosis, xerosis, and half-and-half nail in hemodialysis patients was determined to be 48.03%, 52.85%, 17.57%, 51.14%, and 18.50%, respectively. A multicenter study (12 hemodialysis centres) in the Tunisia, the overall prevalence of skin discoloration, pruritus, xerosis, and half-and-half nail in hemodialysis patients was reported 60.7%, 56.6%, 52.8%, and 13.5%, respectively. 16 Except for the prevalence of half-and-half nail, the prevalence of skin discoloration and pruritus is lower among Iranian hemodialysis patients. The prevalence of xerosis in our study is similar to Tunisian study. In a recent study in Egypt, the prevalence of pruritus, xerosis, and half-and-half nail was reported to be 52%, 72%, and 41%, respectively. As it is clear, the reported prevalence is higher than our finding about this type of skin complications. 17 More prevalent cutaneous manifestations in a group of Indian hemodialysis patients were xerosis (79%), pallor (60%), pruritus (53%), cutaneous pigmentation (43%), and half-and-half nail (21% In a study conducted in Turkey, nail disorders have been reported in hemodialysis patients and renal transplant recipients. In this study, only 7.7% of hemodialysis patients had half-and-half nail and in general, nail disorders in hemodialysis patients were higher than renal transplant recipients. 19 
| LIMITATIONS
This study provides comprehensive evidences about skin complications among the Iranian ESRD patients. All available sources of data and domestic databases were searched using English/Persian equivalent search terms. As the main limitation of systematic review study, the validity and applicability of our systematic review depend on the quality of the primary studies that are included. As another point, heterogeneity of searched results limits the generalization of our findings. As a limitation of this study is that we could not report the prevalence of skin complications based on related factors. Other one was that we could not extract enough data for estimating of all type of skin complications prevalence in hemodialysis patients. The studies, which were also considered for analysis, might not use the similar criteria for the diagnosis of skin complications.
| CONCLUSION
Skin complications are common in ESRD patients and have negative effects on the quality of life of them. In last year, by providing new advances in the renal replacement therapies, the prevalence of some complications is significantly reduced, but some of these complications do not respond to dialysis. Therefore, early detection of these complications and supportive treatments will reduce mortality and can improve patients' quality of life. Findings of our study could provide practical information on skin complications in Iran. These could be useful for more detailed studies in this field. The presented results also could be used for future complementary analyses in subnational, national, or even global levels.
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